Ryuhei Okuyama

5.8k total citations · 1 hit paper
164 papers, 3.7k citations indexed

About

Ryuhei Okuyama is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ryuhei Okuyama has authored 164 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 55 papers in Immunology and 45 papers in Molecular Biology. Recurrent topics in Ryuhei Okuyama's work include Cutaneous Melanoma Detection and Management (27 papers), Immunotherapy and Immune Responses (21 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Ryuhei Okuyama is often cited by papers focused on Cutaneous Melanoma Detection and Management (27 papers), Immunotherapy and Immune Responses (21 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Ryuhei Okuyama collaborates with scholars based in Japan, United States and United Kingdom. Ryuhei Okuyama's co-authors include Eisaku Ogawa, Setsuya Aiba, Akane Minagawa, Yuki Sato, Hachiro Tagami, Hisashi Uhara, G. Paolo Dotto, Masuo Obinata, Taku Fujimura and Yukiko Kiniwa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Ryuhei Okuyama

158 papers receiving 3.7k citations

Hit Papers

Pathogenesis of psoriasis and development of treatment 2017 2026 2020 2023 2017 100 200 300

Peers

Ryuhei Okuyama
Rainer Zenz Austria
Min Hee Oh United States
Xianying Xing United States
Ling Wu China
Qing‐Sheng Mi United States
Erle Dang China
Ryuhei Okuyama
Citations per year, relative to Ryuhei Okuyama Ryuhei Okuyama (= 1×) peers Laurence Michel

Countries citing papers authored by Ryuhei Okuyama

Since Specialization
Citations

This map shows the geographic impact of Ryuhei Okuyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuhei Okuyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuhei Okuyama more than expected).

Fields of papers citing papers by Ryuhei Okuyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuhei Okuyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuhei Okuyama. The network helps show where Ryuhei Okuyama may publish in the future.

Co-authorship network of co-authors of Ryuhei Okuyama

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuhei Okuyama. A scholar is included among the top collaborators of Ryuhei Okuyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuhei Okuyama. Ryuhei Okuyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hida, Tokimasa, Masashi Idogawa, Sayuri Sato, et al.. (2025). Fusion Gene Detection in Driver Mutation‐Negative Melanomas Using RNA ‐Based Anchored Multiplex Polymerase Chain Reaction. Pigment Cell & Melanoma Research. 38(6). e70056–e70056.
2.
Hida, Tokimasa, Masashi Idogawa, Junji Kato, et al.. (2024). Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan. Cancer Medicine. 13(22). e70360–e70360. 6 indexed citations
3.
Kanda, Shintaro, Takao Ide, Mitsuhisa Komatsu, et al.. (2023). Antiplatelet drugs may increase the risk for checkpoint inhibitor-related pneumonitis in advanced cancer patients. ESMO Open. 8(6). 102030–102030. 6 indexed citations
4.
Morita, Akimichi, Yukari Okubo, Shinichi Imafuku, et al.. (2023). Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review study. SHILAP Revista de lepidopterología. 2(2). 261–272. 2 indexed citations
5.
Sano, Kenji, et al.. (2023). Type 1 interferon signature and cytotoxic T lymphocyte activation targeted against sweat ducts in inflammatory acquired idiopathic generalized anhidrosis. Journal of the European Academy of Dermatology and Venereology. 37(10). 2124–2132. 2 indexed citations
6.
Ashida, Atsuko, Shuta Tomida, Tokuro Iwabuchi, et al.. (2022). Persistent alteration of the skin microbiome in patients with skin rash after receiving EGFR inhibitor treatment. Experimental Dermatology. 32(5). 671–677. 1 indexed citations
7.
Nakamura, Kenta & Ryuhei Okuyama. (2022). Changes in the Immune Cell Repertoire for the Treatment of Malignant Melanoma. International Journal of Molecular Sciences. 23(21). 12991–12991. 5 indexed citations
8.
Kiniwa, Yukiko, Kenta Nakamura, Atsuko Ashida, et al.. (2021). Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation. BMC Cancer. 21(1). 19 indexed citations
9.
Nakamura, Kenta, Atsuko Ashida, Yukiko Kiniwa, & Ryuhei Okuyama. (2021). Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma. Archives of Dermatological Research. 314(9). 887–895. 2 indexed citations
10.
Suzuki, Rika, et al.. (2020). Successful treatment of cutaneous infection due to Purpureocillium lilacinum using voriconazole. The Journal of Dermatology. 47(9). e342–e343. 3 indexed citations
11.
Tsutsumida, Arata, Satoshi Fukushima, Kenji Yokota, et al.. (2019). Japanese real‐world study of sequential nivolumab and ipilimumab treament in melanoma. The Journal of Dermatology. 46(11). 947–955. 13 indexed citations
12.
Hayashi, Kôichi, Ryuhei Okuyama, & Hisashi Uhara. (2016). Water‐based correction fluid is a useful skin marker for determination of the tumor margin of basal cell carcinoma under high‐frequency ultrasound. The Journal of Dermatology. 43(7). 823–825. 5 indexed citations
13.
Hidaka, Takanori, Eisaku Ogawa, Eri Kobayashi, et al.. (2016). The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin. Nature Immunology. 18(1). 64–73. 214 indexed citations
14.
Shirai, T, Minori Kodaira, Nagaaki Katoh, et al.. (2015). Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma. Japanese Journal of Clinical Oncology. 46(1). 86–88. 108 indexed citations
15.
Ogawa, Eisaku, et al.. (2013). Current State of Therapies, Including with Biologics, for Psoriasis and the Prospects for Coordination on Treatment in Nagano Prefecture. The Nishinihon Journal of Dermatology. 75(4). 346–349. 1 indexed citations
16.
Ohashi, Atsuko, et al.. (2011). Cutaneous angiosarcoma of the leg showing radiation sensitivity. Australasian Journal of Dermatology. 53(3). e51–3. 2 indexed citations
17.
Sugawara, M., et al.. (2008). A Case of Pencil-Core Granuloma. The Nishinihon Journal of Dermatology. 70(3). 265–268.
18.
Okuyama, Ryuhei, et al.. (2006). A Case of Contact Dermatitis due to Fiblast Spray, a Product of Basic Fibroblast Growth Factor. The Nishinihon Journal of Dermatology. 68(3). 248–250. 1 indexed citations
19.
Okuyama, Ryuhei, Claudio Talora, Eisaku Ogawa, et al.. (2004). High Commitment of Embryonic Keratinocytes to Terminal Differentiation through a Notch1-caspase 3 Regulatory Mechanism. Developmental Cell. 6(4). 551–562. 160 indexed citations
20.
Terui, Tadashi, Ryuhei Okuyama, & Hachiro Tagami. (2001). Molecular events occurring behind ultraviolet-induced skin inflammation. Current Opinion in Allergy and Clinical Immunology. 1(5). 461–467. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026